Translate

2

Hepatitis C - Finally A Cure! - Medical Breakthrough


Globally, about 170 million people are infected with hepatitis C; the disease kills 350,000 people annually. Approximately 4 million Americans are infected with hepatitis C.

Until recently, treatment for hepatitis C fell into the good-but-not-great category, with only around 70 percent of patients being cured. And that was after as much as 48 weeks of a strict anti-viral drug regimen, including injections of interferon—which causes a number of debilitating side effects (loss of vision, sepsis, heart failure, and leucopenia.).

Sofosbuvir is a much more potent killer of hepatitis C, with success in as many as 95 percent of patients. Even more, the medication only has to be administered for half of the time and has a remarkable safety profile.

Sofosbuvir is the first compound in the NS5B polymerase inhibitor class. It interferes with the virus’s ability to replicate and make proteins. Sofosbuvir, is offering impressive cure rates for Hepatitis C patients with two subtypes of the disease – 93% among those with genotype 2 and 61% among participants with genotype 3.

This is the first time in medical research that we have a cure for a viral disease. Both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) recommended approval of Sofosbuvir. The new potent antiviral drug combo (Sofosbuvir combination with ribavirin) may eventually replace interferon use for the majority of patients with hepatitis C.

The prevalence of hepatitis C infection ranges from 0.4 to 3.5 per cent among the European member states. Often patients have no symptoms, so the majority of hepatitis C infected people don’t know they are infected.

The hepatitis C virus spreads by contact with infected blood, such as injection drug use, sexual contact or through blood transfusions. Hepatitis C, if left untreated, can progress to cirrhosis, liver cancer and liver failure.

Of the 7 major genotypes of hepatitis C, 1, 2 and 3 are the most common. In the USA, genotype 1 is the most common, while the most prevalent in Europe are genotypes 2 and 3. In the Indian subcontinent genotype 3 is the most common.

Source Article: https://globalmedicaldiscovery.com/breakthrough-discoveries/finally-cure-hepatitis-c/

Other Articles Of Interest:
Hepatitis C - Finally A Cure! - Medical Breakthrough
Medical Advances To Watch In 2014
Why Are The Chinese Controlling The Rain
Why Do Koalas Hug Trees?
Young Illegal Immigrants Can Defer Deportation
Illegal Immigrants Are Being Shipped To Arizona 
Why Are Mega-Mergaers Killing Innovation?


Other Videos Of Interest:
Naples Plastic Surgery
Naples Dentist
Real Estate Video Marketing
Video Marketing Services
Naples Web Design
Naples SEO
Naples Real Estate
Dental Scrap

© 2014 all rights reserved



Post a Comment

  1. I experienced dark urine and ribs pain, so I went to the hospital for treatment and I was diagnosed for chronic HEPATITIS B. The doctor gave me drugs to slowdown the viral load which later worsens the ailment because the drugs weren’t effective anymore. And I was so scared because they say it has no cure, I told a friend about it and luckily he told me he ones battled same problem in the past but he was saved by Dr. Iyabiye. He gave me his contact and I reached him and I became well and tested negative after the treatment. Here is his contact if you have such case. Contact: +234-815-857-7300, (iyabiyehealinghome@gmail.com)

    ReplyDelete
  2. You also can select coasters as business 3D printer tasks to promote. Many families use coasters to guard the tables from sizzling cups. Millions of smartphone customers prefer to get new telephone cases every so often. Of course, you'll need to design one thing distinctive to attract consideration. Many 3D printing Rechargeable Candle Lighters tasks look easy, but they are genius.

    ReplyDelete

 
Top